G15150A

# **General Information**

| **Position** | **15150** | **Variant** | **m.15150G\>A** | **Locus** | **MT\-CYB** | **Amino\-AcidChange** | **W135Term** |
| --- | --- | --- | --- | --- | --- | --- | --- |
| **Homoplasmy** | \- | **Heteroplasmy** | \+ | **APOGEE2** | NA | **Pathogenicity** | Cfrm \[LP] |

"Pathogenicity" status is derived from published literature or predictions from bioinformatics tools. Researchers and clinicians are cautioned that additional data and/or analysis may still be necessary to confirm the pathological significance of these variants. For more information, please see [Mitofam Info](https://mitofam.com/doc/385/).

# **Pedigree Information**

The **m.15150G\>A** variant in MT\-CYB has been reported in 1 pedigree. To date, 1 carrier has been reported. Reported mutation loads ranged from 0% to 60%, with a median of 0% overall; affected carriers showed mutation loads from 0% to 60%, with a median of 0%. In one affected carrier, the mutation was undetectable in blood (0%), fibroblasts (0%), and myoblasts (0%) but exceeded 20% in muscle (60%). The main clinical manifestations among affected carriers included isolated exercise intolerance.

| **No.** | **Position** | **Variant** | **Family ID** | **Nationality** | **Diseases** | **Unaffected Maternal Relatives** | **Affected Maternal Relatives** | **Publication Year** | **PMID/Ref** | **Note** |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1 | 15150 | m.15150G\>A | G15150A\-F1 | France | Exercise intolerance | 0 | 0 | 2001 | [11464242](https://pubmed.ncbi.nlm.nih.gov/11464242/) | PDF supports G15150A/W135X, not G15150C. |

# **Carrier Information**

| **No.** | **Position** | **Variant** | **Family ID** | **Carrier ID** | **Type (Fam/De novo/Uninf)** | **Gender (F/M)** | **Proband (Y/N)** | **Affected (Y/N)** | **Die/Alive(D/A)** | **Age** | **Blood Mutant Level** | **Muscle Mutant level** | **Urine Mutant level** | **Other Mutant level** | **Clinical Features** | **Note** |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1 | 15150 | m.15150G\>A | G15150A\-F1 | G15150A\-F1\-I1 | De novo | ND | Y | Y | ND | ND | 0 | 60% | / | 0% (F); 0% (myoblasts) | Isolated exercise intolerance | PDF supports G15150A/W135X; mother blood negative. |

For abbreviations and other usage instructions, please see [Mitofam Info](https://mitofam.com/doc/385/).